Pediatric Clinic, Centre Hospitalier de Luxembourg, Luxembourg, GD de Luxembourg.
Pediatr Diabetes. 2013 Sep;14(6):422-8. doi: 10.1111/j.1399-5448.2012.00922.x. Epub 2012 Sep 10.
To investigate whether center differences in glycemic control are present in prepubertal children <11 yr with type 1 diabetes mellitus.
This cross-sectional study involved 18 pediatric centers worldwide. All children, <11 y with a diabetes duration ≥12 months were invited to participate. Case Record Forms included information on clinical characteristics, insulin regimens, diabetic ketoacidosis (DKA), severe hypoglycemia, language difficulties, and comorbidities. Hemoglobin A1c (HbA1c) was measured centrally by liquid chromatography (DCCT aligned, range: 4.4-6.3%; IFFC: 25-45 mmol/mol).
A total of 1133 children participated (mean age: 8.0 ± 2.1 y; females: 47.5%, mean diabetes duration: 3.8 ± 2.1 y). HbA1c (overall mean: 8.0 ± 1.0%; range: 7.3-8.9%) and severe hypoglycemia frequency (mean 21.7 events per 100 patient-years), but not DKA, differed significantly between centers (p < 0.001 resp. p = 0.179). Language difficulties showed a negative relationship with HbA1c (8.3 ± 1.2% vs. 8.0 ± 1.0%; p = 0.036). Frequency of blood glucose monitoring demonstrated a significant but weak association with HbA1c (r = -0.17; p < 0.0001). Although significant different HbA1c levels were obtained with diverse insulin regimens (range: 7.3-8.5%; p < 0.001), center differences remained after adjusting for insulin regimen (p < 0.001). Differences between insulin regimens were no longer significant after adjusting for center effect (p = 0.199).
Center differences in metabolic outcomes are present in children <11 yr, irrespective of diabetes duration, age, or gender. The incidence of severe hypoglycemia is lower than in adolescents despite achieving better glycemic control. Insulin regimens show a significant relationship with HbA1c but do not explain center differences. Each center's effectiveness in using specific treatment strategies remains the key factor for outcome.
研究<11 岁的 1 型糖尿病患儿血糖控制是否存在中心差异。
这是一项涉及全球 18 个儿科中心的横断面研究。所有糖尿病病程≥12 个月的<11 岁儿童均被邀请参加。病例记录包括临床特征、胰岛素方案、糖尿病酮症酸中毒(DKA)、严重低血糖、语言障碍和合并症的信息。糖化血红蛋白(HbA1c)由液相色谱法(DCCT 校准,范围:4.4-6.3%;IFFC:25-45mmol/mol)在中心进行测量。
共有 1133 名儿童参与(平均年龄:8.0±2.1 岁;女性:47.5%,平均糖尿病病程:3.8±2.1 年)。HbA1c(整体平均值:8.0±1.0%;范围:7.3-8.9%)和严重低血糖的频率(平均每 100 名患者年发生 21.7 次事件),但 DKA 不同中心之间差异显著(p<0.001 和 p=0.179)。语言障碍与 HbA1c 呈负相关(8.3±1.2%比 8.0±1.0%;p=0.036)。血糖监测的频率与 HbA1c 呈显著但较弱的关联(r=-0.17;p<0.0001)。尽管不同胰岛素方案得到的 HbA1c 水平明显不同(范围:7.3-8.5%;p<0.001),但调整胰岛素方案后,中心差异仍然存在(p<0.001)。调整中心效应后,胰岛素方案之间的差异不再显著(p=0.199)。
<11 岁的儿童存在代谢结果的中心差异,无论糖尿病病程、年龄或性别如何。尽管血糖控制更好,但严重低血糖的发生率低于青少年。胰岛素方案与 HbA1c 呈显著相关,但不能解释中心差异。每个中心使用特定治疗策略的效果仍然是结果的关键因素。